Comprehensive review of the detection methods for synthetic cannabinoids and cathinones Akira NameraMaho KawamuraMasataka Nagao Review Article Open access 06 March 2015 Pages: 175 - 194
AH-7921: the list of new psychoactive opioids is expanded Maria KatselouIoannis PapoutsisSotiris Athanaselis Review Article Open access 21 February 2015 Pages: 195 - 201
Quantification of methylone and metabolites in rat and human plasma by liquid chromatography-tandem mass spectrometry Kayla N. EllefsenMarta ConcheiroMarilyn A. Huestis Original Article 05 February 2015 Pages: 202 - 212
Identification and quantitation of 5-fluoro-ADB-PINACA and MAB-CHMINACA in dubious herbal products Amin WuritaKoutaro HasegawaOsamu Suzuki Original Article 03 February 2015 Pages: 213 - 220
Simultaneous quantification of 37 synthetic cannabinoid metabolites in human urine by liquid chromatography-tandem mass spectrometry Moonhee JangIlchung ShinWonkyung Yang Original Article 04 February 2015 Pages: 221 - 234
Simultaneous plasma and oral fluid morphine and codeine concentrations after controlled administration of poppy seeds with known opiate content Matthew N. NewmeyerMarta ConcheiroMarilyn A. Huestis Original Article 14 February 2015 Pages: 235 - 243
A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products Nahoko UchiyamaYoshihiko ShimokawaTakashi Hakamatsuka Original Article Open access 11 February 2015 Pages: 244 - 259
Cannabinoid disposition in oral fluid after controlled vaporizer administration with and without alcohol Rebecca L. HartmanSébastien AnizanMarilyn A. Huestis Original Article 10 March 2015 Pages: 260 - 278
Urinary excretion and metabolism of the α-pyrrolidinophenone designer drug 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one (PV9) in humans Noriaki ShimaHidenao KakehashiHitoshi Tsuchihashi Original Article 08 April 2015 Pages: 279 - 294
Identification of AB-FUBINACA metabolites in human hepatocytes and urine using high-resolution mass spectrometry Marisol S. CastanetoAriane WohlfarthMarilyn A. Huestis Original Article 21 April 2015 Pages: 295 - 310
Identification of analogs of LY2183240 and the LY2183240 2′-isomer in herbal products Akiko AsadaTakahiro DoiYoshiyuki Sawabe Original Article 19 April 2015 Pages: 311 - 320
Development and validation of a liquid chromatography–mass spectrometry procedure after solid-phase extraction for detection of 19 doping peptides in human urine Monica MazzarinoValeria CalvaresiFrancesco Botrè Original Article 27 May 2015 Pages: 321 - 337
Differentiation of regioisomeric chloroamphetamine analogs using gas chromatography–chemical ionization-tandem mass spectrometry Shoko NegishiYukiko NakazonoHiroyuki Inoue Original Article Open access 19 May 2015 Pages: 338 - 347
Identification and quantification of 4′-methoxy-α-pyrrolidinobutiophenone (4-MeOPBP) in human plasma and urine using LC–TOF-MS in an autopsy case Kaori Shintani-IshidaMami NakamuraHiroshi Ikegaya Original Article 16 May 2015 Pages: 348 - 354
Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues Samuel D. BanisterJordyn StuartMichael Kassiou Original Article 31 May 2015 Pages: 355 - 366
A new pyrazole-carboxamide type synthetic cannabinoid AB-CHFUPYCA [N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide] identified in illegal products Nahoko UchiyamaKazuhiro AsakawaTakashi Hakamatsuka Original Article 12 June 2015 Pages: 367 - 373
Evaluation of the neurochemical effects of methoxetamine using brain microdialysis in mice Yuki FuchigamiXunsing FuKenichiro Nakashima Short Communication 18 February 2015 Pages: 374 - 379
Postmortem distribution of MAB-CHMINACA in body fluids and solid tissues of a human cadaver Koutaro HasegawaAmin WuritaOsamu Suzuki Short Communication Open access 10 March 2015 Pages: 380 - 387
Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites Laura M. HuppertzPhilippe BiselBjoern Moosmann Short Communication 21 April 2015 Pages: 388 - 395
A case of fatal intoxication due to the new designer drug 25B-NBOMe Ken-ichi YoshidaKanju SakaTetsuya Sakamoto Case Report 21 April 2015 Pages: 396 - 401
Diphenidine and its metabolites in blood and urine analyzed by MALDI-Q-TOF mass spectrometry Kayoko MinakataItaru YamagishiOsamu Suzuki Letter to the Editor 31 March 2015 Pages: 402 - 408
Identification and quantitation of mifepristone and its N-demethyl metabolite in the plasma of an aborted fetus by liquid chromatography–quadrupole–time-of-flight–mass spectrometry (LC–Q–TOFMS) and ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS–MS) Akira IshiiKei ZaitsuHiroshi Seno Letter to the Editor 12 June 2015 Pages: 409 - 412
